Suppr超能文献

选择性5-羟色胺再摄取抑制剂、劳拉西泮和可待因致死性中毒。

Fatal intoxication with a selective serotonin reuptake inhibitor, lorazepam, and codeine.

作者信息

Filter Emily R, Gorczynski Laura, Fernandes John R

机构信息

Department of Pathology and Molecular Medicine, Hamilton Health Sciences Centre, McMaster University, Hamilton, Ontario, Canada.

出版信息

Am J Forensic Med Pathol. 2007 Dec;28(4):361-3. doi: 10.1097/PAF.0b013e31815b4c37.

Abstract

Selective serotonin reuptake inhibitors were introduced in 1987 as an alternative treatment option for patients with depression or certain anxiety disorders. Unfortunately, this greater use has prompted a corresponding increase in reports of more severe side effects and fatalities, with a majority of fatalities occurring due to coingestion of selective serotonin reuptake inhibitors with other substances or serotonergic drugs. We report a case which exemplifies one such fatality related to sertraline, lorazepam, and codeine coingestion. A brief discussion of the presumed mechanism by which death occurred will be offered.

摘要

选择性5-羟色胺再摄取抑制剂于1987年被引入,作为抑郁症或某些焦虑症患者的一种替代治疗选择。不幸的是,这种更广泛的使用导致了更严重副作用和死亡报告的相应增加,大多数死亡是由于同时摄入选择性5-羟色胺再摄取抑制剂与其他物质或5-羟色胺能药物所致。我们报告了一例这样的死亡病例,该病例与舍曲林、劳拉西泮和可待因同时摄入有关。将对推测的死亡发生机制进行简要讨论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验